nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—ABCB1—esophageal cancer	0.238	1	CbGaD
Cabazitaxel—SLCO1B3—Methotrexate—esophageal cancer	0.0902	0.249	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—esophageal cancer	0.0752	0.208	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—esophageal cancer	0.0643	0.178	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—esophageal cancer	0.0525	0.145	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—esophageal cancer	0.0417	0.115	CbGbCtD
Cabazitaxel—ABCB1—Cisplatin—esophageal cancer	0.0232	0.064	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—esophageal cancer	0.015	0.0415	CbGbCtD
Cabazitaxel—Neutropenic sepsis—Capecitabine—esophageal cancer	0.00469	0.0378	CcSEcCtD
Cabazitaxel—Hydronephrosis—Capecitabine—esophageal cancer	0.00424	0.0342	CcSEcCtD
Cabazitaxel—Ureteric obstruction—Methotrexate—esophageal cancer	0.00369	0.0297	CcSEcCtD
Cabazitaxel—Peripheral sensory neuropathy—Capecitabine—esophageal cancer	0.00285	0.0229	CcSEcCtD
Cabazitaxel—TUBB3—digestive system—esophageal cancer	0.0025	0.0357	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—esophageal cancer	0.00249	0.0356	CbGeAlD
Cabazitaxel—TUBA4A—bronchus—esophageal cancer	0.00245	0.0351	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—esophageal cancer	0.0024	0.0343	CbGeAlD
Cabazitaxel—TUBA4A—trachea—esophageal cancer	0.0022	0.0315	CbGeAlD
Cabazitaxel—TUBB3—lung—esophageal cancer	0.00208	0.0298	CbGeAlD
Cabazitaxel—TUBB2B—bronchus—esophageal cancer	0.0019	0.0272	CbGeAlD
Cabazitaxel—TUBA4A—digestive system—esophageal cancer	0.0019	0.0271	CbGeAlD
Cabazitaxel—Paclitaxel—NR1I2—esophageal cancer	0.00186	0.143	CrCbGaD
Cabazitaxel—Docetaxel—NR1I2—esophageal cancer	0.00186	0.143	CrCbGaD
Cabazitaxel—Febrile neutropenia—Cisplatin—esophageal cancer	0.00183	0.0148	CcSEcCtD
Cabazitaxel—SLCO1B3—lung—esophageal cancer	0.00183	0.0261	CbGeAlD
Cabazitaxel—TUBB—bronchus—esophageal cancer	0.0018	0.0257	CbGeAlD
Cabazitaxel—TUBB6—epithelium—esophageal cancer	0.00179	0.0256	CbGeAlD
Cabazitaxel—TUBB2A—bronchus—esophageal cancer	0.00179	0.0256	CbGeAlD
Cabazitaxel—TUBB6—bronchus—esophageal cancer	0.00176	0.0252	CbGeAlD
Cabazitaxel—TUBB—smooth muscle tissue—esophageal cancer	0.00176	0.0252	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—esophageal cancer	0.00175	0.025	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—esophageal cancer	0.00173	0.0247	CbGeAlD
Cabazitaxel—TUBB2B—trachea—esophageal cancer	0.00171	0.0244	CbGeAlD
Cabazitaxel—TUBB—trachea—esophageal cancer	0.00161	0.0231	CbGeAlD
Cabazitaxel—TUBB2A—trachea—esophageal cancer	0.00161	0.023	CbGeAlD
Cabazitaxel—TUBB6—trachea—esophageal cancer	0.00158	0.0227	CbGeAlD
Cabazitaxel—TUBA4A—lung—esophageal cancer	0.00158	0.0226	CbGeAlD
Cabazitaxel—Paclitaxel—BCL2—esophageal cancer	0.00154	0.118	CrCbGaD
Cabazitaxel—Docetaxel—BCL2—esophageal cancer	0.00154	0.118	CrCbGaD
Cabazitaxel—TUBB4B—bronchus—esophageal cancer	0.00153	0.0219	CbGeAlD
Cabazitaxel—TUBB4A—digestive system—esophageal cancer	0.00152	0.0217	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—esophageal cancer	0.0015	0.0215	CbGeAlD
Cabazitaxel—Mucosal inflammation—Capecitabine—esophageal cancer	0.00147	0.0118	CcSEcCtD
Cabazitaxel—TUBB2B—digestive system—esophageal cancer	0.00147	0.021	CbGeAlD
Cabazitaxel—Haemorrhoids—Capecitabine—esophageal cancer	0.00138	0.0111	CcSEcCtD
Cabazitaxel—TUBB2A—digestive system—esophageal cancer	0.00138	0.0198	CbGeAlD
Cabazitaxel—TUBB4B—trachea—esophageal cancer	0.00138	0.0197	CbGeAlD
Cabazitaxel—TUBB6—digestive system—esophageal cancer	0.00136	0.0195	CbGeAlD
Cabazitaxel—Febrile neutropenia—Capecitabine—esophageal cancer	0.00135	0.0109	CcSEcCtD
Cabazitaxel—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00134	0.0108	CcSEcCtD
Cabazitaxel—Infection—Carboplatin—esophageal cancer	0.00133	0.0107	CcSEcCtD
Cabazitaxel—TUBB4A—lung—esophageal cancer	0.00127	0.0181	CbGeAlD
Cabazitaxel—SLCO1B1—digestive system—esophageal cancer	0.00126	0.0181	CbGeAlD
Cabazitaxel—TUBB2B—lung—esophageal cancer	0.00123	0.0175	CbGeAlD
Cabazitaxel—Cellulitis—Cisplatin—esophageal cancer	0.00121	0.00977	CcSEcCtD
Cabazitaxel—Intestinal obstruction—Capecitabine—esophageal cancer	0.00119	0.00961	CcSEcCtD
Cabazitaxel—TUBB4B—digestive system—esophageal cancer	0.00118	0.0169	CbGeAlD
Cabazitaxel—TUBB—lung—esophageal cancer	0.00116	0.0166	CbGeAlD
Cabazitaxel—TUBB2A—lung—esophageal cancer	0.00115	0.0165	CbGeAlD
Cabazitaxel—Ileus—Capecitabine—esophageal cancer	0.00115	0.00925	CcSEcCtD
Cabazitaxel—Pain—Carboplatin—esophageal cancer	0.00115	0.00924	CcSEcCtD
Cabazitaxel—TUBB6—lung—esophageal cancer	0.00114	0.0163	CbGeAlD
Cabazitaxel—Mucosal inflammation—Methotrexate—esophageal cancer	0.00109	0.00881	CcSEcCtD
Cabazitaxel—TUBA4A—lymph node—esophageal cancer	0.00108	0.0155	CbGeAlD
Cabazitaxel—Herpes zoster—Capecitabine—esophageal cancer	0.00108	0.0087	CcSEcCtD
Cabazitaxel—Docetaxel—CYP1B1—esophageal cancer	0.00107	0.0821	CrCbGaD
Cabazitaxel—Paclitaxel—CYP1B1—esophageal cancer	0.00107	0.0821	CrCbGaD
Cabazitaxel—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00106	0.00855	CcSEcCtD
Cabazitaxel—Body temperature increased—Carboplatin—esophageal cancer	0.00106	0.00854	CcSEcCtD
Cabazitaxel—Docetaxel—EGFR—esophageal cancer	0.00101	0.0775	CrCbGaD
Cabazitaxel—Febrile neutropenia—Methotrexate—esophageal cancer	0.00101	0.0081	CcSEcCtD
Cabazitaxel—Deep vein thrombosis—Methotrexate—esophageal cancer	0.000995	0.00801	CcSEcCtD
Cabazitaxel—TUBB4B—lung—esophageal cancer	0.000989	0.0142	CbGeAlD
Cabazitaxel—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.000901	0.00725	CcSEcCtD
Cabazitaxel—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000901	0.00725	CcSEcCtD
Cabazitaxel—Oropharyngeal pain—Capecitabine—esophageal cancer	0.000894	0.0072	CcSEcCtD
Cabazitaxel—Cellulitis—Capecitabine—esophageal cancer	0.000894	0.0072	CcSEcCtD
Cabazitaxel—Lacrimation increased—Capecitabine—esophageal cancer	0.000883	0.00711	CcSEcCtD
Cabazitaxel—TUBB4A—lymph node—esophageal cancer	0.000868	0.0124	CbGeAlD
Cabazitaxel—Renal failure acute—Cisplatin—esophageal cancer	0.000868	0.00699	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00086	0.00692	CcSEcCtD
Cabazitaxel—TUBB2B—lymph node—esophageal cancer	0.000839	0.012	CbGeAlD
Cabazitaxel—Paclitaxel—ABCC2—esophageal cancer	0.000835	0.064	CrCbGaD
Cabazitaxel—Docetaxel—ABCC2—esophageal cancer	0.000835	0.064	CrCbGaD
Cabazitaxel—Herpes zoster—Methotrexate—esophageal cancer	0.000804	0.00647	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000801	0.00645	CcSEcCtD
Cabazitaxel—TUBB—lymph node—esophageal cancer	0.000794	0.0113	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—esophageal cancer	0.000789	0.0113	CbGeAlD
Cabazitaxel—Paclitaxel—CYP19A1—esophageal cancer	0.000785	0.0603	CrCbGaD
Cabazitaxel—Urinary incontinence—Capecitabine—esophageal cancer	0.000785	0.00632	CcSEcCtD
Cabazitaxel—Colitis—Capecitabine—esophageal cancer	0.000781	0.00629	CcSEcCtD
Cabazitaxel—TUBB6—lymph node—esophageal cancer	0.000779	0.0111	CbGeAlD
Cabazitaxel—Candida infection—Capecitabine—esophageal cancer	0.000777	0.00625	CcSEcCtD
Cabazitaxel—Dehydration—Cisplatin—esophageal cancer	0.000745	0.006	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000732	0.00589	CcSEcCtD
Cabazitaxel—Hypokalaemia—Cisplatin—esophageal cancer	0.000729	0.00587	CcSEcCtD
Cabazitaxel—Breast disorder—Cisplatin—esophageal cancer	0.000724	0.00583	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000721	0.00581	CcSEcCtD
Cabazitaxel—Sepsis—Capecitabine—esophageal cancer	0.000706	0.00568	CcSEcCtD
Cabazitaxel—TUBB4B—lymph node—esophageal cancer	0.000677	0.00968	CbGeAlD
Cabazitaxel—CYP3A5—digestive system—esophageal cancer	0.000649	0.00928	CbGeAlD
Cabazitaxel—Renal failure acute—Capecitabine—esophageal cancer	0.00064	0.00515	CcSEcCtD
Cabazitaxel—Hot flush—Capecitabine—esophageal cancer	0.000631	0.00508	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Capecitabine—esophageal cancer	0.000626	0.00504	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Capecitabine—esophageal cancer	0.000623	0.00502	CcSEcCtD
Cabazitaxel—Renal failure—Cisplatin—esophageal cancer	0.000607	0.00489	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000605	0.00487	CcSEcCtD
Cabazitaxel—Cardiac failure—Capecitabine—esophageal cancer	0.000605	0.00487	CcSEcCtD
Cabazitaxel—Lethargy—Capecitabine—esophageal cancer	0.000603	0.00485	CcSEcCtD
Cabazitaxel—Conjunctivitis—Cisplatin—esophageal cancer	0.0006	0.00483	CcSEcCtD
Cabazitaxel—Cystitis noninfective—Methotrexate—esophageal cancer	0.000591	0.00476	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00059	0.00475	CcSEcCtD
Cabazitaxel—Pain in extremity—Capecitabine—esophageal cancer	0.00059	0.00475	CcSEcCtD
Cabazitaxel—Cystitis—Methotrexate—esophageal cancer	0.000585	0.00471	CcSEcCtD
Cabazitaxel—ABCG2—lung—esophageal cancer	0.000584	0.00835	CbGeAlD
Cabazitaxel—Cardiac arrest—Capecitabine—esophageal cancer	0.000561	0.00452	CcSEcCtD
Cabazitaxel—Urinary retention—Capecitabine—esophageal cancer	0.000561	0.00452	CcSEcCtD
Cabazitaxel—Dehydration—Capecitabine—esophageal cancer	0.000549	0.00442	CcSEcCtD
Cabazitaxel—Bladder pain—Methotrexate—esophageal cancer	0.000547	0.00441	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Cisplatin—esophageal cancer	0.000547	0.00441	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Cisplatin—esophageal cancer	0.000545	0.00438	CcSEcCtD
Cabazitaxel—Urethral disorder—Cisplatin—esophageal cancer	0.000543	0.00437	CcSEcCtD
Cabazitaxel—CYP3A5—lung—esophageal cancer	0.000542	0.00775	CbGeAlD
Cabazitaxel—Dry skin—Capecitabine—esophageal cancer	0.000541	0.00436	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000539	0.00434	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Capecitabine—esophageal cancer	0.000539	0.00434	CcSEcCtD
Cabazitaxel—Hypokalaemia—Capecitabine—esophageal cancer	0.000537	0.00433	CcSEcCtD
Cabazitaxel—Breast disorder—Capecitabine—esophageal cancer	0.000534	0.0043	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000532	0.00428	CcSEcCtD
Cabazitaxel—Sepsis—Methotrexate—esophageal cancer	0.000525	0.00423	CcSEcCtD
Cabazitaxel—Gastritis—Capecitabine—esophageal cancer	0.000523	0.00421	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000521	0.00419	CcSEcCtD
Cabazitaxel—Eye disorder—Cisplatin—esophageal cancer	0.000518	0.00417	CcSEcCtD
Cabazitaxel—Tinnitus—Cisplatin—esophageal cancer	0.000517	0.00416	CcSEcCtD
Cabazitaxel—Cardiac disorder—Cisplatin—esophageal cancer	0.000514	0.00414	CcSEcCtD
Cabazitaxel—Flushing—Cisplatin—esophageal cancer	0.000514	0.00414	CcSEcCtD
Cabazitaxel—Abdominal distension—Capecitabine—esophageal cancer	0.000514	0.00414	CcSEcCtD
Cabazitaxel—Influenza—Capecitabine—esophageal cancer	0.00051	0.00411	CcSEcCtD
Cabazitaxel—Immune system disorder—Cisplatin—esophageal cancer	0.0005	0.00403	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Cisplatin—esophageal cancer	0.000499	0.00402	CcSEcCtD
Cabazitaxel—Arrhythmia—Cisplatin—esophageal cancer	0.000495	0.00399	CcSEcCtD
Cabazitaxel—Alopecia—Cisplatin—esophageal cancer	0.00049	0.00394	CcSEcCtD
Cabazitaxel—CYP3A4—digestive system—esophageal cancer	0.000487	0.00696	CbGeAlD
Cabazitaxel—Erythema—Cisplatin—esophageal cancer	0.000482	0.00388	CcSEcCtD
Cabazitaxel—Malnutrition—Cisplatin—esophageal cancer	0.000482	0.00388	CcSEcCtD
Cabazitaxel—Dysuria—Capecitabine—esophageal cancer	0.000477	0.00384	CcSEcCtD
Cabazitaxel—Neutropenia—Capecitabine—esophageal cancer	0.000477	0.00384	CcSEcCtD
Cabazitaxel—Renal failure acute—Methotrexate—esophageal cancer	0.000476	0.00383	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000474	0.00382	CcSEcCtD
Cabazitaxel—Muscle spasms—Cisplatin—esophageal cancer	0.000464	0.00373	CcSEcCtD
Cabazitaxel—Weight decreased—Capecitabine—esophageal cancer	0.000462	0.00372	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Capecitabine—esophageal cancer	0.00046	0.00371	CcSEcCtD
Cabazitaxel—Pneumonia—Capecitabine—esophageal cancer	0.000458	0.00369	CcSEcCtD
Cabazitaxel—Infestation—Capecitabine—esophageal cancer	0.000455	0.00366	CcSEcCtD
Cabazitaxel—Infestation NOS—Capecitabine—esophageal cancer	0.000455	0.00366	CcSEcCtD
Cabazitaxel—ABCB1—epithelium—esophageal cancer	0.000453	0.00648	CbGeAlD
Cabazitaxel—Lethargy—Methotrexate—esophageal cancer	0.000449	0.00361	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Cisplatin—esophageal cancer	0.000448	0.0036	CcSEcCtD
Cabazitaxel—Renal failure—Capecitabine—esophageal cancer	0.000447	0.0036	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000446	0.00359	CcSEcCtD
Cabazitaxel—Anaemia—Cisplatin—esophageal cancer	0.000446	0.00359	CcSEcCtD
Cabazitaxel—Urinary tract infection—Capecitabine—esophageal cancer	0.000442	0.00356	CcSEcCtD
Cabazitaxel—Conjunctivitis—Capecitabine—esophageal cancer	0.000442	0.00356	CcSEcCtD
Cabazitaxel—Malaise—Cisplatin—esophageal cancer	0.000435	0.0035	CcSEcCtD
Cabazitaxel—Haematuria—Capecitabine—esophageal cancer	0.000434	0.00349	CcSEcCtD
Cabazitaxel—Leukopenia—Cisplatin—esophageal cancer	0.000432	0.00348	CcSEcCtD
Cabazitaxel—Myalgia—Cisplatin—esophageal cancer	0.000411	0.00331	CcSEcCtD
Cabazitaxel—Anxiety—Cisplatin—esophageal cancer	0.000409	0.0033	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000408	0.00328	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Capecitabine—esophageal cancer	0.000406	0.00327	CcSEcCtD
Cabazitaxel—Discomfort—Cisplatin—esophageal cancer	0.000406	0.00327	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Capecitabine—esophageal cancer	0.000403	0.00325	CcSEcCtD
Cabazitaxel—Oedema peripheral—Capecitabine—esophageal cancer	0.000402	0.00324	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Capecitabine—esophageal cancer	0.000401	0.00323	CcSEcCtD
Cabazitaxel—ABCB1—trachea—esophageal cancer	0.000401	0.00573	CbGeAlD
Cabazitaxel—Urethral disorder—Capecitabine—esophageal cancer	0.0004	0.00322	CcSEcCtD
Cabazitaxel—ABCG2—lymph node—esophageal cancer	0.000399	0.00571	CbGeAlD
Cabazitaxel—Breast disorder—Methotrexate—esophageal cancer	0.000397	0.0032	CcSEcCtD
Cabazitaxel—Oedema—Cisplatin—esophageal cancer	0.000394	0.00317	CcSEcCtD
Cabazitaxel—Infection—Cisplatin—esophageal cancer	0.000391	0.00315	CcSEcCtD
Cabazitaxel—Nervous system disorder—Cisplatin—esophageal cancer	0.000386	0.00311	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Cisplatin—esophageal cancer	0.000385	0.0031	CcSEcCtD
Cabazitaxel—Tachycardia—Cisplatin—esophageal cancer	0.000384	0.00309	CcSEcCtD
Cabazitaxel—Skin disorder—Cisplatin—esophageal cancer	0.000382	0.00308	CcSEcCtD
Cabazitaxel—Eye disorder—Capecitabine—esophageal cancer	0.000382	0.00307	CcSEcCtD
Cabazitaxel—Tinnitus—Capecitabine—esophageal cancer	0.000381	0.00307	CcSEcCtD
Cabazitaxel—Flushing—Capecitabine—esophageal cancer	0.000379	0.00305	CcSEcCtD
Cabazitaxel—Cardiac disorder—Capecitabine—esophageal cancer	0.000379	0.00305	CcSEcCtD
Cabazitaxel—Anorexia—Cisplatin—esophageal cancer	0.000375	0.00302	CcSEcCtD
Cabazitaxel—Angiopathy—Capecitabine—esophageal cancer	0.000371	0.00298	CcSEcCtD
Cabazitaxel—Immune system disorder—Capecitabine—esophageal cancer	0.000369	0.00297	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Capecitabine—esophageal cancer	0.000368	0.00296	CcSEcCtD
Cabazitaxel—Hypotension—Cisplatin—esophageal cancer	0.000368	0.00296	CcSEcCtD
Cabazitaxel—Chills—Capecitabine—esophageal cancer	0.000366	0.00295	CcSEcCtD
Cabazitaxel—Arrhythmia—Capecitabine—esophageal cancer	0.000365	0.00294	CcSEcCtD
Cabazitaxel—Alopecia—Capecitabine—esophageal cancer	0.000361	0.00291	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000359	0.00289	CcSEcCtD
Cabazitaxel—Mental disorder—Capecitabine—esophageal cancer	0.000358	0.00288	CcSEcCtD
Cabazitaxel—Malnutrition—Capecitabine—esophageal cancer	0.000356	0.00286	CcSEcCtD
Cabazitaxel—Erythema—Capecitabine—esophageal cancer	0.000356	0.00286	CcSEcCtD
Cabazitaxel—Dysuria—Methotrexate—esophageal cancer	0.000355	0.00286	CcSEcCtD
Cabazitaxel—Neutropenia—Methotrexate—esophageal cancer	0.000355	0.00286	CcSEcCtD
Cabazitaxel—Paraesthesia—Cisplatin—esophageal cancer	0.000353	0.00285	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000353	0.00284	CcSEcCtD
Cabazitaxel—Dyspnoea—Cisplatin—esophageal cancer	0.000351	0.00283	CcSEcCtD
Cabazitaxel—Dysgeusia—Capecitabine—esophageal cancer	0.000348	0.0028	CcSEcCtD
Cabazitaxel—ABCB1—digestive system—esophageal cancer	0.000345	0.00493	CbGeAlD
Cabazitaxel—Back pain—Capecitabine—esophageal cancer	0.000344	0.00277	CcSEcCtD
Cabazitaxel—Decreased appetite—Cisplatin—esophageal cancer	0.000342	0.00276	CcSEcCtD
Cabazitaxel—Muscle spasms—Capecitabine—esophageal cancer	0.000342	0.00275	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—esophageal cancer	0.000341	0.00274	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00034	0.00274	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—esophageal cancer	0.000339	0.00273	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—esophageal cancer	0.000339	0.00273	CcSEcCtD
Cabazitaxel—Pain—Cisplatin—esophageal cancer	0.000337	0.00271	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—esophageal cancer	0.000333	0.00268	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Capecitabine—esophageal cancer	0.00033	0.00266	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—esophageal cancer	0.000329	0.00265	CcSEcCtD
Cabazitaxel—Anaemia—Capecitabine—esophageal cancer	0.000329	0.00265	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cisplatin—esophageal cancer	0.000324	0.00261	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—esophageal cancer	0.000323	0.0026	CcSEcCtD
Cabazitaxel—Malaise—Capecitabine—esophageal cancer	0.000321	0.00258	CcSEcCtD
Cabazitaxel—Vertigo—Capecitabine—esophageal cancer	0.000319	0.00257	CcSEcCtD
Cabazitaxel—Leukopenia—Capecitabine—esophageal cancer	0.000318	0.00256	CcSEcCtD
Cabazitaxel—Body temperature increased—Cisplatin—esophageal cancer	0.000311	0.00251	CcSEcCtD
Cabazitaxel—Cough—Capecitabine—esophageal cancer	0.00031	0.0025	CcSEcCtD
Cabazitaxel—Paclitaxel—ABCB1—esophageal cancer	0.000307	0.0236	CrCbGaD
Cabazitaxel—Docetaxel—ABCB1—esophageal cancer	0.000307	0.0236	CrCbGaD
Cabazitaxel—Hypertension—Capecitabine—esophageal cancer	0.000307	0.00247	CcSEcCtD
Cabazitaxel—Arthralgia—Capecitabine—esophageal cancer	0.000303	0.00244	CcSEcCtD
Cabazitaxel—Chest pain—Capecitabine—esophageal cancer	0.000303	0.00244	CcSEcCtD
Cabazitaxel—Myalgia—Capecitabine—esophageal cancer	0.000303	0.00244	CcSEcCtD
Cabazitaxel—Anxiety—Capecitabine—esophageal cancer	0.000302	0.00243	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000301	0.00242	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—esophageal cancer	0.0003	0.00242	CcSEcCtD
Cabazitaxel—Discomfort—Capecitabine—esophageal cancer	0.000299	0.00241	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—esophageal cancer	0.000298	0.0024	CcSEcCtD
Cabazitaxel—Dry mouth—Capecitabine—esophageal cancer	0.000296	0.00238	CcSEcCtD
Cabazitaxel—Confusional state—Capecitabine—esophageal cancer	0.000293	0.00236	CcSEcCtD
Cabazitaxel—Oedema—Capecitabine—esophageal cancer	0.00029	0.00234	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cisplatin—esophageal cancer	0.00029	0.00234	CcSEcCtD
Cabazitaxel—Infection—Capecitabine—esophageal cancer	0.000288	0.00232	CcSEcCtD
Cabazitaxel—ABCB1—lung—esophageal cancer	0.000288	0.00412	CbGeAlD
Cabazitaxel—Nervous system disorder—Capecitabine—esophageal cancer	0.000285	0.00229	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—esophageal cancer	0.000284	0.00229	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Capecitabine—esophageal cancer	0.000284	0.00229	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—esophageal cancer	0.000283	0.00228	CcSEcCtD
Cabazitaxel—Tachycardia—Capecitabine—esophageal cancer	0.000283	0.00228	CcSEcCtD
Cabazitaxel—Asthenia—Cisplatin—esophageal cancer	0.000282	0.00227	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—esophageal cancer	0.000282	0.00227	CcSEcCtD
Cabazitaxel—Skin disorder—Capecitabine—esophageal cancer	0.000282	0.00227	CcSEcCtD
Cabazitaxel—Anorexia—Capecitabine—esophageal cancer	0.000277	0.00223	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—esophageal cancer	0.000276	0.00222	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—esophageal cancer	0.000275	0.00221	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—esophageal cancer	0.000274	0.00221	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—esophageal cancer	0.000273	0.0022	CcSEcCtD
Cabazitaxel—Hypotension—Capecitabine—esophageal cancer	0.000271	0.00218	CcSEcCtD
Cabazitaxel—Diarrhoea—Cisplatin—esophageal cancer	0.000269	0.00217	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—esophageal cancer	0.000269	0.00216	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—esophageal cancer	0.000266	0.00215	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—esophageal cancer	0.000265	0.00213	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—esophageal cancer	0.000265	0.00213	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000264	0.00213	CcSEcCtD
Cabazitaxel—Paraesthesia—Capecitabine—esophageal cancer	0.000261	0.0021	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—esophageal cancer	0.000259	0.00209	CcSEcCtD
Cabazitaxel—Dyspnoea—Capecitabine—esophageal cancer	0.000259	0.00208	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—esophageal cancer	0.000256	0.00206	CcSEcCtD
Cabazitaxel—Dyspepsia—Capecitabine—esophageal cancer	0.000255	0.00206	CcSEcCtD
Cabazitaxel—Decreased appetite—Capecitabine—esophageal cancer	0.000252	0.00203	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000251	0.00202	CcSEcCtD
Cabazitaxel—Vomiting—Cisplatin—esophageal cancer	0.00025	0.00202	CcSEcCtD
Cabazitaxel—Fatigue—Capecitabine—esophageal cancer	0.00025	0.00201	CcSEcCtD
Cabazitaxel—Pain—Capecitabine—esophageal cancer	0.000248	0.002	CcSEcCtD
Cabazitaxel—Constipation—Capecitabine—esophageal cancer	0.000248	0.002	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—esophageal cancer	0.000246	0.00198	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—esophageal cancer	0.000245	0.00197	CcSEcCtD
Cabazitaxel—Feeling abnormal—Capecitabine—esophageal cancer	0.000239	0.00193	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—esophageal cancer	0.000239	0.00192	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—esophageal cancer	0.000238	0.00191	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000237	0.00191	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—esophageal cancer	0.000237	0.00191	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—esophageal cancer	0.000234	0.00188	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—esophageal cancer	0.000231	0.00186	CcSEcCtD
Cabazitaxel—Body temperature increased—Capecitabine—esophageal cancer	0.000229	0.00185	CcSEcCtD
Cabazitaxel—Abdominal pain—Capecitabine—esophageal cancer	0.000229	0.00185	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—esophageal cancer	0.000225	0.00181	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—esophageal cancer	0.000225	0.00181	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—esophageal cancer	0.000225	0.00181	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000224	0.0018	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—esophageal cancer	0.000223	0.00179	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—esophageal cancer	0.000218	0.00175	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—esophageal cancer	0.000215	0.00173	CcSEcCtD
Cabazitaxel—Hypersensitivity—Capecitabine—esophageal cancer	0.000214	0.00172	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—esophageal cancer	0.000212	0.00171	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—esophageal cancer	0.000212	0.0017	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—esophageal cancer	0.00021	0.00169	CcSEcCtD
Cabazitaxel—Asthenia—Capecitabine—esophageal cancer	0.000208	0.00168	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—esophageal cancer	0.000206	0.00166	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—esophageal cancer	0.000202	0.00163	CcSEcCtD
Cabazitaxel—Diarrhoea—Capecitabine—esophageal cancer	0.000199	0.0016	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—esophageal cancer	0.000197	0.00281	CbGeAlD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000197	0.00158	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—esophageal cancer	0.000194	0.00156	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—esophageal cancer	0.000193	0.00155	CcSEcCtD
Cabazitaxel—Dizziness—Capecitabine—esophageal cancer	0.000192	0.00155	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—esophageal cancer	0.00019	0.00153	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—esophageal cancer	0.000188	0.00151	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000187	0.0015	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—esophageal cancer	0.000186	0.0015	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—esophageal cancer	0.000185	0.00149	CcSEcCtD
Cabazitaxel—Vomiting—Capecitabine—esophageal cancer	0.000185	0.00149	CcSEcCtD
Cabazitaxel—Headache—Capecitabine—esophageal cancer	0.000182	0.00146	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—esophageal cancer	0.000178	0.00143	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000177	0.00142	CcSEcCtD
Cabazitaxel—Nausea—Capecitabine—esophageal cancer	0.000172	0.00139	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—esophageal cancer	0.000171	0.00138	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—esophageal cancer	0.000171	0.00138	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—esophageal cancer	0.000159	0.00128	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—esophageal cancer	0.000155	0.00125	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—esophageal cancer	0.000148	0.00119	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—esophageal cancer	0.000143	0.00115	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—esophageal cancer	0.000137	0.00111	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—esophageal cancer	0.000135	0.00109	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—esophageal cancer	0.000128	0.00103	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—esophageal cancer	3.23e-05	0.000168	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ENO1—esophageal cancer	3.22e-05	0.000167	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS1—esophageal cancer	3.22e-05	0.000167	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.21e-05	0.000167	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PIK3CA—esophageal cancer	3.21e-05	0.000167	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—esophageal cancer	3.21e-05	0.000167	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	3.2e-05	0.000166	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ADH1B—esophageal cancer	3.19e-05	0.000166	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PSME2—esophageal cancer	3.17e-05	0.000165	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PSME1—esophageal cancer	3.17e-05	0.000165	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—esophageal cancer	3.14e-05	0.000163	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC52A3—esophageal cancer	3.12e-05	0.000162	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BLVRB—esophageal cancer	3.12e-05	0.000162	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALOX15—esophageal cancer	3.12e-05	0.000162	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.12e-05	0.000162	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	3.12e-05	0.000162	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—esophageal cancer	3.11e-05	0.000161	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	3.1e-05	0.000161	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	3.07e-05	0.00016	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC10A2—esophageal cancer	3.06e-05	0.000159	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CA1—esophageal cancer	3.06e-05	0.000159	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.05e-05	0.000158	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TYMP—esophageal cancer	3.05e-05	0.000158	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—esophageal cancer	3.04e-05	0.000158	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN1A—esophageal cancer	3.04e-05	0.000158	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.99e-05	0.000155	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTO1—esophageal cancer	2.97e-05	0.000155	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TPI1—esophageal cancer	2.97e-05	0.000155	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP26A1—esophageal cancer	2.96e-05	0.000154	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—esophageal cancer	2.95e-05	0.000153	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—esophageal cancer	2.93e-05	0.000152	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—EP300—esophageal cancer	2.89e-05	0.00015	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALOX15—esophageal cancer	2.89e-05	0.00015	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—esophageal cancer	2.87e-05	0.000149	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALDOB—esophageal cancer	2.85e-05	0.000148	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—esophageal cancer	2.81e-05	0.000146	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CA2—esophageal cancer	2.8e-05	0.000145	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.79e-05	0.000145	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN1A—esophageal cancer	2.78e-05	0.000144	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.77e-05	0.000144	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.77e-05	0.000144	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TPI1—esophageal cancer	2.75e-05	0.000143	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTO1—esophageal cancer	2.75e-05	0.000143	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GAPDH—esophageal cancer	2.75e-05	0.000143	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP1B1—esophageal cancer	2.74e-05	0.000142	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.74e-05	0.000142	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.72e-05	0.000141	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CRABP1—esophageal cancer	2.72e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BLVRB—esophageal cancer	2.72e-05	0.000141	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.72e-05	0.000141	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC10A2—esophageal cancer	2.65e-05	0.000138	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CA1—esophageal cancer	2.65e-05	0.000138	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—EP300—esophageal cancer	2.64e-05	0.000137	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALDOB—esophageal cancer	2.64e-05	0.000137	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLCE1—esophageal cancer	2.6e-05	0.000135	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ADH7—esophageal cancer	2.6e-05	0.000135	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GNG7—esophageal cancer	2.59e-05	0.000134	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—esophageal cancer	2.57e-05	0.000134	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP19A1—esophageal cancer	2.57e-05	0.000134	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GAPDH—esophageal cancer	2.54e-05	0.000132	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CRABP1—esophageal cancer	2.52e-05	0.000131	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—esophageal cancer	2.52e-05	0.000131	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—esophageal cancer	2.49e-05	0.00013	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CA2—esophageal cancer	2.43e-05	0.000126	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALDH2—esophageal cancer	2.43e-05	0.000126	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GNG7—esophageal cancer	2.4e-05	0.000124	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.37e-05	0.000123	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.35e-05	0.000122	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HMOX1—esophageal cancer	2.35e-05	0.000122	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CA1—esophageal cancer	2.31e-05	0.00012	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.31e-05	0.00012	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTT1—esophageal cancer	2.31e-05	0.00012	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.3e-05	0.00012	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—esophageal cancer	2.3e-05	0.00012	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ADH1B—esophageal cancer	2.28e-05	0.000119	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.28e-05	0.000118	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	2.28e-05	0.000118	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.27e-05	0.000118	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ADH7—esophageal cancer	2.26e-05	0.000117	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.26e-05	0.000117	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ABCB1—esophageal cancer	2.25e-05	0.000117	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000117	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.23e-05	0.000116	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.23e-05	0.000116	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TYMP—esophageal cancer	2.18e-05	0.000113	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ENO1—esophageal cancer	2.16e-05	0.000112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS1—esophageal cancer	2.16e-05	0.000112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.16e-05	0.000112	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000111	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PSME1—esophageal cancer	2.13e-05	0.000111	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PSME2—esophageal cancer	2.13e-05	0.000111	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP26A1—esophageal cancer	2.12e-05	0.00011	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CA2—esophageal cancer	2.11e-05	0.00011	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP2A6—esophageal cancer	2.11e-05	0.00011	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALOX15—esophageal cancer	2.07e-05	0.000107	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—esophageal cancer	2.07e-05	0.000107	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.01e-05	0.000105	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ENO1—esophageal cancer	2e-05	0.000104	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS1—esophageal cancer	2e-05	0.000104	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2e-05	0.000104	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.98e-05	0.000103	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TPI1—esophageal cancer	1.97e-05	0.000103	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTO1—esophageal cancer	1.97e-05	0.000103	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PSME1—esophageal cancer	1.97e-05	0.000102	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PSME2—esophageal cancer	1.97e-05	0.000102	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLCE1—esophageal cancer	1.97e-05	0.000102	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ADH7—esophageal cancer	1.97e-05	0.000102	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.95e-05	0.000101	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALDOB—esophageal cancer	1.89e-05	9.83e-05	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—esophageal cancer	1.89e-05	9.82e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TYMP—esophageal cancer	1.89e-05	9.82e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.86e-05	9.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.85e-05	9.63e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.84e-05	9.55e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.84e-05	9.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.82e-05	9.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.81e-05	9.37e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.79e-05	9.31e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	1.73e-05	8.97e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ADH1B—esophageal cancer	1.72e-05	8.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GNG7—esophageal cancer	1.72e-05	8.92e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.71e-05	8.88e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TPI1—esophageal cancer	1.71e-05	8.88e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.7e-05	8.85e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.7e-05	8.84e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.69e-05	8.75e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.67e-05	8.7e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.67e-05	8.7e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TYMP—esophageal cancer	1.65e-05	8.55e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.64e-05	8.51e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.62e-05	8.39e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.61e-05	8.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.6e-05	8.32e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.6e-05	8.31e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.58e-05	8.21e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.58e-05	8.19e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.58e-05	8.19e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.56e-05	8.12e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALOX15—esophageal cancer	1.56e-05	8.11e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.55e-05	8.03e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.53e-05	7.95e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.51e-05	7.86e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.51e-05	7.86e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CREBBP—esophageal cancer	1.51e-05	7.82e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TPI1—esophageal cancer	1.49e-05	7.73e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTO1—esophageal cancer	1.49e-05	7.73e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GNG7—esophageal cancer	1.49e-05	7.72e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HMOX1—esophageal cancer	1.46e-05	7.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.43e-05	7.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO1—esophageal cancer	1.43e-05	7.45e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALDOB—esophageal cancer	1.43e-05	7.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.42e-05	7.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CA1—esophageal cancer	1.42e-05	7.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PSME2—esophageal cancer	1.41e-05	7.34e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PSME1—esophageal cancer	1.41e-05	7.34e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ABCB1—esophageal cancer	1.4e-05	7.28e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.39e-05	7.24e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GAPDH—esophageal cancer	1.37e-05	7.14e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.37e-05	7.12e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CRABP1—esophageal cancer	1.36e-05	7.07e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NOS3—esophageal cancer	1.35e-05	7e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.33e-05	6.89e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.33e-05	6.88e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.31e-05	6.8e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.31e-05	6.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CA2—esophageal cancer	1.3e-05	6.76e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GNG7—esophageal cancer	1.3e-05	6.73e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO1—esophageal cancer	1.24e-05	6.45e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.24e-05	6.45e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—esophageal cancer	1.23e-05	6.4e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PSME2—esophageal cancer	1.22e-05	6.36e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PSME1—esophageal cancer	1.22e-05	6.36e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.22e-05	6.33e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALDH2—esophageal cancer	1.21e-05	6.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ADH7—esophageal cancer	1.21e-05	6.29e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—esophageal cancer	1.15e-05	6e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.15e-05	5.95e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.14e-05	5.94e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.14e-05	5.93e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS1—esophageal cancer	1.08e-05	5.62e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO1—esophageal cancer	1.08e-05	5.62e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.08e-05	5.62e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.07e-05	5.55e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PSME2—esophageal cancer	1.07e-05	5.54e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PSME1—esophageal cancer	1.07e-05	5.54e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.06e-05	5.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.06e-05	5.48e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.05e-05	5.43e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—esophageal cancer	1.03e-05	5.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TYMP—esophageal cancer	1.01e-05	5.27e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CREBBP—esophageal cancer	1.01e-05	5.25e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—esophageal cancer	1e-05	5.21e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.93e-06	5.16e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.87e-06	5.13e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.62e-06	5e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CREBBP—esophageal cancer	9.37e-06	4.86e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.2e-06	4.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TPI1—esophageal cancer	9.18e-06	4.77e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.18e-06	4.77e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.06e-06	4.71e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NOS3—esophageal cancer	9.06e-06	4.7e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.89e-06	4.62e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.8e-06	4.57e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.7e-06	4.52e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.65e-06	4.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.47e-06	4.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.39e-06	4.36e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NOS3—esophageal cancer	8.39e-06	4.36e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—esophageal cancer	8.28e-06	4.3e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GNG7—esophageal cancer	7.98e-06	4.15e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HMOX1—esophageal cancer	7.89e-06	4.1e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—esophageal cancer	7.67e-06	3.98e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	7.59e-06	3.94e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.48e-06	3.88e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.11e-06	3.69e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.03e-06	3.65e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—esophageal cancer	6.89e-06	3.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CREBBP—esophageal cancer	6.71e-06	3.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO1—esophageal cancer	6.67e-06	3.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.67e-06	3.46e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.58e-06	3.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PSME1—esophageal cancer	6.57e-06	3.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PSME2—esophageal cancer	6.57e-06	3.41e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—esophageal cancer	6.38e-06	3.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NOS3—esophageal cancer	6.01e-06	3.12e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.81e-06	3.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.67e-06	2.94e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.5e-06	2.85e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.33e-06	2.77e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NOS3—esophageal cancer	5.2e-06	2.7e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	5.1e-06	2.65e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CREBBP—esophageal cancer	5.06e-06	2.63e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.86e-06	2.53e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.76e-06	2.47e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—esophageal cancer	4.72e-06	2.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.67e-06	2.42e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—esophageal cancer	4.57e-06	2.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NOS3—esophageal cancer	4.53e-06	2.35e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—esophageal cancer	4.15e-06	2.15e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—esophageal cancer	3.96e-06	2.06e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—esophageal cancer	3.45e-06	1.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.38e-06	1.76e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.12e-06	1.62e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.93e-06	1.52e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NOS3—esophageal cancer	2.79e-06	1.45e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.55e-06	1.33e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.55e-06	1.32e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—esophageal cancer	2.12e-06	1.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.57e-06	8.16e-06	CbGpPWpGaD
